Comparative Analysis of the Chemotherapy-Related Cognitive Impairments in Patients with Breast Cancer: A Community-Based Research

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3.
   PubMed Web of Science ®Google Scholar
• Lee ES, Lee MK, Kim SH, Ro JS, Kang HS, Kim SW, et al. Health-related quality of life in survivors with breast cancer 1 year after diagnosis compared with the general population: a prospective cohort study. Ann Surg. 2011;253(1):101–108. doi:10.1097/SLA.0b013e3181f662ce.
   PubMed Web of Science ®Google Scholar
• Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res. 2018;27(8):2077–2086. doi:10.1007/s11136-018-1866-8.
   PubMed Web of Science ®Google Scholar
• Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94(6):828–834. doi:10.1038/sj.bjc.6603029.
   PubMed Web of Science ®Google Scholar
• Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3(4):223. doi:10.1016/j.critrevonc.2007.06.001.
   PubMed Web of Science ®Google Scholar
• Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–934. doi:10.1016/j.ctrv.2012.05.002.
   PubMed Web of Science ®Google Scholar
• Horowitz TS, Suls J, Treviño M. A call for a neuroscience approach to cancer-related cognitive impairment. Trends Neurosci. 2018;41(8):493–496. doi:10.1016/j.tins.2018.05.001.
   PubMed Web of Science ®Google Scholar
• Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer. 2011;19(10):1647–1656. doi:10.1007/s00520-010-0997-4.
   PubMed Web of Science ®Google Scholar
• Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. JCO. 2012;30(29):3578–3587. doi:10.1200/JCO.2011.39.5640.
   PubMed Web of Science ®Google Scholar
• Henderson FM, Cross AJ, Baraniak AR. A new normal with chemobrain’: experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open. 2019;6(1):2055102919832234. doi:10.1177/2055102919832234.
   Web of Science ®Google Scholar
• Li M, Caeyenberghs K. Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: a systematic review. Neurosci Biobehav Rev. 2018;92:304–317. doi:10.1016/j.neubiorev.2018.05.019.
   PubMed Web of Science ®Google Scholar
• Henneghan A. Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer. 2016;24(1):481–497. doi:10.1007/s00520-015-2927-y.
   PubMed Web of Science ®Google Scholar
• Gutenkunst SL, Vardy JL, Dhillon HM, Bell ML. Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems. Support Care Cancer. 2021;29(3):1377–1386. doi:10.1007/s00520-020-05616-5.
   PubMed Web of Science ®Google Scholar
• Nourbala AA, Bagheri YS, Mohammad K. The validation of general health questionnaire-28 as a psychiatric screening tool. Hakim Res J. 2009;11(4):47–53.
   Google Scholar
• Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian‐language version of the Beck Depression Inventory‐Second edition: BDI‐II‐PERSIAN. Depress Anxiety. 2005;21(4):185–192. doi:10.1002/da.20070.
   PubMed Web of Science ®Google Scholar
• Kaviani H, Mousavi A. Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI). Tehran Univ Med J. 2008;66(2):136–140.
   Google Scholar
• Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013;36(3–4):242–250. doi:10.1159/000351671.
   PubMed Web of Science ®Google Scholar
• Pouretemad HR, Khatibi A, Ganjavi A, Shams J, Zarei M. Validation of Addenbrooke’s cognitive examination (ACE) in a Persian-speaking population. Dement Geriatr Cogn Disord. 2009;28(4):343–347. doi:10.1159/000252772.
   PubMed Web of Science ®Google Scholar
• Task selection guide: Cambridge Brain Sciences. Available from: https://www.cambridgebrainsciences.com/assets/resources/task-selection-guide.pdf.
   Google Scholar
• Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, et al. NCCN practice guidelines for cancer-related fatigue. Oncology. 2000;14(11A):151–161.
   PubMed Web of Science ®Google Scholar
• Abrahams H, Gielissen M, Schmits I, Verhagen C, Rovers M, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27(6):965–974. doi:10.1093/annonc/mdw099.
   PubMed Web of Science ®Google Scholar
• Gullett JM, Cohen RA, Yang GS, Menzies VS, Fieo RA, Kelly DL, et al. Relationship of fatigue with cognitive performance in women with early‐stage breast cancer over 2 years. Psychooncology. 2019;28(5):997–1003. doi:10.1002/pon.5028.
   PubMed Web of Science ®Google Scholar
• Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12(4):537–559. doi:10.1007/s11764-018-0692-x.
   PubMed Web of Science ®Google Scholar
• Pullens MJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology. 2010;19(11):1127–1138. doi:10.1002/pon.1673.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jung SO, Kim H, Abraham I. Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients. Psychooncology. 2020;29(4):617–631. doi:10.1002/pon.5339.
   PubMed Web of Science ®Google Scholar
• Hadi N, Asad ER, Taleei A. Anxiety, depression and anger in breast cancer patients compared with the general population in Shiraz, Southern Iran. Iran Red Crescent Med J. 2009;11(3):312–317.
   Web of Science ®Google Scholar
• Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007;11(1):6–15. doi:10.1016/j.ejon.2006.02.005.
   PubMed Web of Science ®Google Scholar
• Ibrahim EY, Domenicano I, Nyhan K, Elfil M, Mougalian SS, Cartmel B, et al. Cognitive effects and depression associated with taxane-based chemotherapy in breast cancer survivors: a meta-analysis. Front Oncol. 2021;11:642382. doi:10.3389/fonc.2021.642382.
   PubMed Web of Science ®Google Scholar
• Zunini RAL, Scherling C, Wallis N, Collins B, MacKenzie J, Bielajew C, et al. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav. 2013;7(4):460–477. doi:10.1007/s11682-012-9213-0.
   PubMed Web of Science ®Google Scholar
• Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester cancer center–community clinical oncology program. JCO. 2010;28(2):292–298. doi:10.1200/JCO.2009.22.5011.
   PubMed Web of Science ®Google Scholar
• Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725–746. doi:10.1016/j.jpain.2010.12.005.
   PubMed Web of Science ®Google Scholar
• Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry. 2017;29(5):389–402. doi:10.1080/09540261.2017.1288090.
   PubMed Web of Science ®Google Scholar
• Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20(1):76–89. doi:10.1080/138540491005875.
   PubMed Web of Science ®Google Scholar
• Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips K-A. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005;59(1):60–70. doi:10.1016/j.bandc.2005.05.001.
   PubMed Web of Science ®Google Scholar
• Bernstein LJ, McCreath GA, Komeylian Z, Rich JB. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis. Neurosci Biobehav Rev. 2017;83:417–428. doi:10.1016/j.neubiorev.2017.10.028.
   PubMed Web of Science ®Google Scholar
• Vossel S, Geng JJ, Fink GR. Dorsal and ventral attention systems: distinct neural circuits but collaborative roles. Neuroscientist. 2014;20(2):150–159. doi:10.1177/1073858413494269.
   PubMed Web of Science ®Google Scholar
• Lanssens A, Pizzamiglio G, Mantini D, Gillebert CR. Role of the dorsal attention network in distracter suppression based on features. Cogn Neurosci. 2020;11(1–2):37–46. doi:10.1080/17588928.2019.1683525.
   PubMed Web of Science ®Google Scholar
• Majerus S, Péters F, Bouffier M, Cowan N, Phillips C. The dorsal attention network reflects both encoding load and top–down control during working memory. J Cogn Neurosci. 2018;30(2):144–159. doi:10.1080/17588928.2019.1683525.
   Google Scholar
• Chen X, Li J, Ren J, Hu X, Zhu C, Tian Y, et al. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psychooncology. 2014;23(10):1165–1171. doi:10.1002/pon.3539.
   PubMed Web of Science ®Google Scholar
• da Costa R, Passos GF, Quintão NL, Fernandes ES, Maia JRL, Campos MM, et al. Taxane‐induced neurotoxicity: pathophysiology and therapeutic perspectives. Br J Pharmacol. 2020;177(14):3127–3146. doi:10.1111/bph.15086.
   PubMed Web of Science ®Google Scholar
• Ren X, Boriero D, Chaiswing L, Bondada S, Clair DKS, Butterfield DA. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1088–1097. doi:10.1016/j.bbadis.2019.02.007.
   PubMed Web of Science ®Google Scholar